Reboxetine

CHEMBL14370 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

313.4 g/mol

LogP

3.0

Phase

4

A selective norepinephrine reuptake inhibitor used outside the United States to treat major depressive disorder by increasing norepinephrine levels in the brain. It differs from most antidepressants by having minimal effect on serotonin reuptake.

น้ำหนักโมเลกุล

313.4000 g/mol

LogP

3.00

TPSA

39.70 Å²

Lipinski RO5

ผ่าน

ด้านการรักษา

Pain Management Schizophrenia Generalized Anxiety Disorder Stroke Obesity Major Depressive Disorder Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOc1ccccc1OC(c1ccccc1)C1CNCCO1

InChI

InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3

Molecular Formula

C19H23NO3

HBD / HBA

1 / 4

พันธะที่หมุนได้

6

อะตอมหนัก

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A selective norepinephrine reuptake inhibitor used outside the United States to treat major depressive disorder by increasing norepinephrine levels in the brain. It differs from most antidepressants by having minimal effect on serotonin reuptake.

Yes, Reboxetine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL14370. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 127151. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Reboxetine บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C19H23NO3

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.